Shandong Jincheng Pharmaceutical Group Co Ltd
SZSE:300233
Shandong Jincheng Pharmaceutical Group Co Ltd
Operating Income
Shandong Jincheng Pharmaceutical Group Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shandong Jincheng Pharmaceutical Group Co Ltd
SZSE:300233
|
Operating Income
¥275.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-7%
|
CAGR 10-Years
10%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Income
¥2.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Income
¥3.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Income
¥4.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
12%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Income
¥3.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Operating Income
-¥749.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Shandong Jincheng Pharmaceutical Group Co Ltd's Operating Income?
Operating Income
275.2m
CNY
Based on the financial report for Mar 31, 2024, Shandong Jincheng Pharmaceutical Group Co Ltd's Operating Income amounts to 275.2m CNY.
What is Shandong Jincheng Pharmaceutical Group Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
10%
Over the last year, the Operating Income growth was -6%.